Established in 2011, GCA HealthCare Consulting provides strategic advice focused on accelerating the market development of medical devices and biopharmaceutical products. Clients are leaders responsible for guiding the design, development, and sale of medical products. GCA HealthCare’s project work ranges from highly strategic engagements such as pipeline and portfolio optimization, business strategy and planning to tactically focused studies such as, business development, reimbursement, commercialization of new offerings, go-to-market, commercial operations and competitive strategy.
Gino Ariano (GA) BA., BComm., is a Principal at GCA HealthCare Consulting and an experienced medical device and biopharma marketing, sales and reimbursement leader. As an executive team member at Medtronic of Canada, GA established Medtronic’s market development, reimbursement and GR capabilities. GA’s work at Medtronic was instrumental in driving rapid growth in lifesaving implantable defibrillators (ICDs) and in achieving breakthrough public funding for insulin pumps across Canada.
GA has extensive experience bringing new medical device, pharmaceutical and biotech products to market. GA’s core area of strength is in accelerating the market development of medical devices and biopharmaceutical products – enabling patients to benefit from the most advanced therapies available.
GA is passionate supporter of emerging medical technology firms. He currently sits on the Ontario Centres of Excellence (OCE) EPAP Advisory Panel. The mandate of the EPAP panel is to provide OCE with advice to support the commercialization of innovation originating from Ontario’s publicly funded colleges, universities and research hospitals.